Celecoxib in the treatment of obsessive-compulsive disorder
Phase 2
- Conditions
- Obsessive- Cumpulsive Disorder.Obsessive-compulsive disorder
- Registration Number
- IRCT201312181556N56
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Inclusion Criteria: 1-Age between 18-60 years old, 2-Diagnosis of OCD based on DSM IV 3 , Minimum Score of 21 on YALE-BROWN Obsessive-Compulsive Scale
Exclusion Criteria
1- Substance dependence,2- IQ <70,3-any other mental disorder on axis I, 4-Any serious cardiac, renal or hepatic disease ,5- receiving psychotropic medications during the last 6 weeks 6- pregnancy orbreast feeding 7-rising liver transaminases to three times the upper limit of normal or higher
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of symptoms of OCD. Timepoint: Baseline and weeks 2-4-6-8-10 after beginig of treatment. Method of measurement: Y_BOCS( Yale-Brown obsessive compulsive scale).
- Secondary Outcome Measures
Name Time Method